
    
      After 7-11 days of amphotericin B therapy, subjects will be randomized in a 1:1 allocation
      to:

        -  Early initiation of ART (Experimental Group) = ART initiated within 48 hours after study
           entry, OR

        -  Standard initiation of ART (Control Group) = ART at >=4 weeks after study entry

      HIV therapy will be with efavirenz plus nucleoside backbone per national guidelines for first
      line therapy.
    
  